A detailed history of Pine Bridge Investments, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 680,016 shares of MRK stock, worth $86.9 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
680,016
Previous 785,700 13.45%
Holding current value
$86.9 Million
Previous $85.7 Million 4.75%
% of portfolio
0.72%
Previous 0.8%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $12 Million - $13.9 Million
-105,684 Reduced 13.45%
680,016 $89.7 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $45.3 Million - $49.3 Million
452,104 Added 135.52%
785,700 $85.7 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $12.6 Million - $14 Million
-122,138 Reduced 26.8%
333,596 $34.3 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $22.4 Million - $24.4 Million
206,499 Added 82.85%
455,734 $52.6 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $8.29 Million - $9.25 Million
-80,545 Reduced 24.42%
249,235 $26.5 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $2.77 Million - $3.55 Million
-31,649 Reduced 8.76%
329,780 $36.6 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $3.5 Million - $3.94 Million
41,439 Added 12.95%
361,429 $31.1 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $616,239 - $698,537
-7,381 Reduced 2.25%
319,990 $29.2 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $7.97 Million - $8.94 Million
-108,445 Reduced 24.88%
327,371 $26.9 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $24.1 Million - $30.2 Million
333,707 Added 326.81%
435,816 $33.4 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $4.04 Million - $4.44 Million
-56,318 Reduced 35.55%
102,109 $7.67 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $8.38 Million - $9.27 Million
-119,146 Reduced 42.92%
158,427 $12.3 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $9.56 Million - $11.3 Million
138,881 Added 100.14%
277,573 $21.4 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $12.1 Million - $13.4 Million
-168,861 Reduced 54.9%
138,692 $11.3 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $3.37 Million - $3.82 Million
-46,076 Reduced 13.03%
307,553 $25.5 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $23.5 Million - $26.8 Million
-333,954 Reduced 48.57%
353,629 $27.3 Million
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $3.87 Million - $5.36 Million
61,061 Added 9.75%
687,583 $52.9 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $805,745 - $909,190
10,386 Added 1.69%
626,522 $57 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $2.44 Million - $2.65 Million
32,009 Added 5.48%
616,136 $51.9 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $16.1 Million - $18.8 Million
230,377 Added 65.12%
584,127 $49 Million
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $13.5 Million - $15.4 Million
193,730 Added 121.07%
353,750 $29.4 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $6.57 Million - $7.63 Million
100,742 Added 169.95%
160,020 $12.2 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $1.17 Million - $1.38 Million
20,306 Added 52.1%
59,278 $4.21 Million
Q2 2018

Aug 09, 2018

SELL
$50.83 - $59.72 $9.75 Million - $11.5 Million
-191,764 Reduced 83.11%
38,972 $2.37 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $15.2 Million - $17.7 Million
-298,385 Reduced 56.39%
230,736 $12.6 Million
Q4 2017

Feb 09, 2018

SELL
$51.62 - $61.64 $863,757 - $1.03 Million
-16,733 Reduced 3.07%
529,121 $29.8 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $2.66 Million - $2.86 Million
45,352 Added 9.06%
545,854 $35 Million
Q2 2017

Aug 11, 2017

BUY
N/A
500,502
500,502 $32.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.